Correlation Between Dermata Therapeutics and Chromadex Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Chromadex Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Chromadex Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Chromadex Corp, you can compare the effects of market volatilities on Dermata Therapeutics and Chromadex Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Chromadex Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Chromadex Corp.

Diversification Opportunities for Dermata Therapeutics and Chromadex Corp

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dermata and Chromadex is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Chromadex Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chromadex Corp and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Chromadex Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chromadex Corp has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Chromadex Corp go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Chromadex Corp

Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Chromadex Corp. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 3.98 times less risky than Chromadex Corp. The stock trades about -0.32 of its potential returns per unit of risk. The Chromadex Corp is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  367.00  in Chromadex Corp on August 29, 2024 and sell it today you would earn a total of  392.00  from holding Chromadex Corp or generate 106.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dermata Therapeutics  vs.  Chromadex Corp

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Chromadex Corp 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chromadex Corp are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Chromadex Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Dermata Therapeutics and Chromadex Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and Chromadex Corp

The main advantage of trading using opposite Dermata Therapeutics and Chromadex Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Chromadex Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will offset losses from the drop in Chromadex Corp's long position.
The idea behind Dermata Therapeutics and Chromadex Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios